Blog
980 Articles
Final Results of the Daraxonrasib Trial Are Unprecedented
When Dr. Brian Wolpin read the final results from the phase III daraxonrasib trial, everyone was on their feet at the 2026 ASCO meeting.
Accessing Daraxonrasib: A Quick Primer
Daraxonrasib, the first KRAS drug for pancreatic cancer, is now available through an expanded access program, but your physician must apply for you.
2026 AACR Annual Meeting Gives Hope for the Future
Research highlights from the 2026 AACR Meeting featured advances in pancreatic cancer treatment, focusing on KRAS and vaccines,
Large Clinical Trial For Cachexia Treatment
Lead investigator Dr. Jeffrey Crawford reports on the positive results from a cachexia clinical trial of a new immunotherapy drug to treat the condition.
Seven Tips to Navigate the Caregiver Learning Curve
Brooke Dwars learned quickly to manage her husband’s care. Nurse navigator Patricia Gambino and social worker Lauren Shaffer provide other tips for a caregiver.
Certain Oral Microbes May Raise Pancreatic Cancer Risk
Dr. Jiyoung Ahn is leading research into how the oral microbiome is related to the risk of developing pancreatic cancer.